AspirinCyclooxygenase 2Cyclooxygenase 1Cyclooxygenase InhibitorsCyclooxygenase 2 InhibitorsProstaglandin-Endoperoxide SynthasesAnti-Inflammatory Agents, Non-SteroidalPlatelet Aggregation InhibitorsIndomethacinThromboxane B2DinoprostoneProstaglandinsArachidonic AcidIbuprofenPlatelet AggregationIsoenzymesSalicylatesTiclopidinePlatelet Function TestsSulfonamidesPyrazolesThromboxane A2NitrobenzenesBlood PlateletsThromboxanesLipoxygenase Inhibitors6-Ketoprostaglandin F1 alphaEpoprostenolSodium SalicylateArachidonic AcidsDose-Response Relationship, DrugDrug Therapy, CombinationNaproxenLipoxygenaseFlurbiprofenMembrane ProteinsAsthma, Aspirin-InducedFibrinolytic AgentsEicosanoidsThromboxane-A SynthaseDiclofenacMasoprocolHemorrhagePiroxicamPlatelet ActivationBleeding TimeLipoxinsAnticoagulantsWarfarinTablets, Enteric-CoatedGastric MucosaAcetaminophenProstaglandins ETime FactorsStomach UlcerGastrointestinal HemorrhageHydroxyeicosatetraenoic AcidsDouble-Blind MethodArachidonate 5-LipoxygenaseThrombosisIntramolecular OxidoreductasesDinoprostNitric OxideProstaglandins GRisk FactorsMeclofenamic AcidSeminal VesiclesSulfonesSulfinpyrazoneDipyridamoleLactonesDrug InteractionsCells, CulturedReceptors, Prostaglandin EDrug Resistance4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amineTreatment Outcome5,8,11,14-Eicosatetraynoic AcidMyocardial InfarctionProspective StudiesVasodilationProstaglandin AntagonistsThiazinesReceptors, ThromboxaneLeukotrienesSalicylic AcidNitric Oxide SynthaseAnti-Inflammatory AgentsEndothelium, VascularSulindacReye SyndromeStrokeStereoisomerismRNA, Messenger